Who Among U.S. Women of Childbearing Age Can Use GLP-1 Receptor Agonist Treatments

Approximately U.S. women of reproductive age may be eligible for glucagon-like peptide 1 receptor agonist therapy.

• GLP-1 receptor agonists are used for diabetes and weight management.
• Their use may impact pregnancy outcomes.
• The number of eligible women is being estimated.

Simplified